Additional file 2 of Enteral citrulline supplementation versus placebo on SOFA score on day 7 in mechanically ventilated critically ill patients: the IMMUNOCITRE randomized clinical trial

Additional file 2 of Enteral citrulline supplementation versus placebo on SOFA score on day 7 in mechanically ventilated critically ill patients: the IMMUNOCITRE randomized clinical trial

Additional file 2: Figure S2. Secondary outcome evolution from randomization to day 7 in the enteral citrulline supplementation group versus the placebo group of mechanically ventilated critically ill patients in the IMMUNOCITRE Randomized Clinical Trial. A. Total lymphocyte count. B. Circulating mo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Tadié, Jean-Marc, Locher, Clara, Maamar, Adel, Reignier, Jean, Asfar, Pierre, Commereuc, Morgane, Lesouhaitier, Mathieu, Gregoire, Murielle, Le Pabic, Estelle, Bendavid, Claude, Moreau, Caroline, Diehl, Jean-Luc, Gey, Alain, Tartour, Eric, Le Tulzo, Yves, Thibault, Ronan, Terzi, Nicolas, Gacouin, Arnaud, Roussel, Mikael, Delclaux, Christophe, Tarte, Karin, Cynober, Luc
Format: Bild
Sprache:eng
Schlagworte:
FOS: Clinical medicine
Immunology
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Additional file 2: Figure S2. Secondary outcome evolution from randomization to day 7 in the enteral citrulline supplementation group versus the placebo group of mechanically ventilated critically ill patients in the IMMUNOCITRE Randomized Clinical Trial. A. Total lymphocyte count. B. Circulating monocytic myeloid-derived suppressor cell (M-MDSC) count. C. Indoleamine-pyrrole 2,3-dioxygenase (IDO) activity (evaluated by the ratio between plasma concentrations of kynurenine and tryptophan).
DOI:10.6084/m9.figshare.24234134